Metabolic programs define dysfunctional immune responses in severe COVID-19 patientsElizabeth A. Thompson, Jonathan D. Powell, Michael J. Delannoy et al.|Cell Reports|2021Cited by 135
Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipientsElizabeth A. Thompson, Andrea L. Cox, Wabathi Ngecu et al.|JCI Insight|2023Cited by 11
Lipid-Oxidizing B Cells Enable Successful Vaccine Response Despite ImmunosuppressionElizabeth A. Thompson, Justin R. Bailey, Katerina Roznik et al.|SSRN Electronic Journal|2022Cited by 2
Alternative lineage B cells utilizing fatty acid oxidation predict response to third dose COVID vaccination in solid organ transplant recipientsElizabeth A. Thompson, Justin R. Bailey, Katerina Roznik et al.|The Journal of Immunology|2022Cited by 0
Heterologous versus homologous boosting regimens elicit qualitatively distinct, BA.5 cross reactive T cells in transplant recipientsElizabeth A. Thompson, Andrea L. Cox, Wabathi Ngecu et al.|The Journal of Immunology|2023Cited by 0